XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 26, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Options Roll Forward A summary of stock option activity for the Company’s stock-based compensation plans during the thirteen weeks ended March 26, 2023 is as follows:
NUMBER OF OPTIONSWEIGHTED AVERAGE
EXERCISE PRICE
AGGREGATE INTRINSIC VALUE
(in thousands)
WEIGHTED AVERAGE
REMAINING CONTRACTUAL LIFE
(in years)
Outstanding, December 25, 2022
5,115,674 $10.12 $20,981 6.1
Exercised(66,717)$8.45 $503 
Forfeited(49,362)$12.22 
Outstanding, March 26, 2023
4,999,595 $10.12 $26,181 5.8
Exercisable, March 26, 2023
3,076,284 $9.56 $17,819 5.2
Schedule of Fair Value Non-vested Options at Grant Dates
A summary of the non-vested stock options for the Company’s stock-based compensation plans is as follows:
NUMBER OF OPTIONSWEIGHTED AVERAGE GRANT DATE FAIR VALUE
Nonvested, December 25, 2022
2,324,316 $7.31 
Vested (351,643)$6.53 
Forfeited (49,362)$5.19 
Nonvested, March 26, 2023
1,923,311 $7.51 
Schedule of Nonvested Restricted Stock Units Activity A summary of the Company’s RSU activity during the thirteen weeks ended March 26, 2023 is as follows:
RESTRICTED STOCK UNITSWEIGHTED AVERAGE GRANT DATE FAIR VALUE
AGGREGATE INTRINSIC VALUE
(in thousands)
Outstanding, December 25, 2022
38,311 $14.36 $544 
Granted 507,702 $15.52 
Vested (6,854)$14.59 
Outstanding, March 26, 2023
539,159 $15.45 $8,276